New insights highlight clinician support for shared survivorship care and identify key factors for effective implementation.

Pierre Fabre Laboratories have received marketing authorisation in China for BRAFTOVI (encorafenib) in combination with ...

Feeling tired all the time is another possible symptom. Colon cancer can lead to slow, long-term blood loss in the stool, ...

The American Cancer Society estimates by the end of 2025, there will be around 150,000 cases of colon cancer in the U.S., and ...

The American Cancer Society estimates by the end of 2025, there will be around 150,000 cases of colon cancer in the U.S., and ...

Based on data from the BEACON and NAUTICAL studies, regulatory authorities greenlit the combo for later-line patients.

We also found that tumors release a protein called Activin-A, which acts on blood vessels to cause the leakiness and, ultimately, loss of blood vessels in the muscle. When we used a gene therapy to ...

While oncology has relentlessly pursued progress through pharmacological and procedural advances, exercise has occupied a ...

The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs ...

In this randomized controlled trial, patients with resected stage III or high-risk stage II colon cancer who completed ...

Prostate and colorectal cancers are two of the most common cancers affecting men in the U.S., and Black men face ...

(“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that the medical journal Nature has published findings by a team of physician-scientists ...